Harvard Scientist Aims for Rejuvenation Drug Trial
Nhà khoa học David Sinclair dự định thử nghiệm thuốc trẻ hóa toàn thân dựa trên công nghệ tái lập trình hóa học trong cuộc thi do Quỹ XPrize tổ chức.
Harvard researcher David Sinclair plans to test a new anti-aging drug that utilizes chemical reprogramming technology. This initiative is part of a competition hosted by the XPrize Foundation. The drug aims to achieve whole-body rejuvenation. Sinclair's work has previously explored the biological mechanisms of aging. This trial represents a significant step in translating his research into potential human applications. The XPrize competition encourages innovative solutions to global challenges.
This research could potentially lead to breakthroughs in extending human lifespan and improving health in old age.
📌 Kaynak
Bu özet VnExpress (VN) kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →